The UC Irvine Muscle Biology and Disease Research Center and CureDuchenne will host a free community screening of the documentary “The Remarkable Life of Ibelin” on Friday, September 18. The event will take place at the Rivian South Coast Theater in Laguna Beach. While held outside Irvine, the screening directly connects residents to the significant clinical research portfolio and efforts of UC Irvine’s School of Medicine and Medical Center, aiming to raise awareness of Duchenne muscular dystrophy and highlight advancements in muscle disease research, clinical trials, and care.
Doors for the event open at 6:15 p.m., with the film beginning at 7 p.m. Attendees can meet UC Irvine muscle scientists and physicians, and visit educational exhibits, research demonstrations, and resource tables from both UC Irvine and CureDuchenne. Researchers and clinicians will share information on current clinical trials and advances in muscle biology and neuromuscular disease. Following the film, a panel discussion and audience Q&A will feature researchers, clinicians, and patient advocates. The event is free and open to the public, including UC Irvine affiliates.
“The Remarkable Life of Ibelin” tells the story of Mats Steen, a young man with Duchenne muscular dystrophy. After his death at age 25, his family discovered he had built a vibrant community and deep friendships through the online game “World of Warcraft.” The documentary explores disability, connection, and the impact of online communities. It premiered in 2024 at the Sundance Film Festival, where it won the Audience Award and the Directing Award in the World Cinema Documentary Competition, also earning a Peabody Award.
The September 18 event is scheduled during Muscular Dystrophy Awareness Month. Its purpose is to foster connections between the experiences of patients and families and the scientists, clinicians, and advocates working to advance research, treatments, and care for Duchenne and other muscle diseases.
UC Irvine’s commitment to this field is substantial. The UC Irvine Medical Center currently conducts eight active clinical trials for muscular dystrophies, including gene therapy studies and those evaluating emerging treatments. The UC Irvine Muscle Biology and Disease Research Center, established in 2023 and directed by Armando Villalta, Ph.D., brings together approximately 80 scientists, clinicians, and trainees. This interdisciplinary center promotes research, clinical translation, and education in skeletal muscle biology, accelerating discoveries in muscle regeneration and neuromuscular disease. It also expands education and workforce development through graduate courses, collaborative initiatives, and an NIH-supported T32 training program.
CureDuchenne, a global nonprofit headquartered in Newport Beach, focuses on improving and extending the lives of individuals with Duchenne muscular dystrophy. For over two decades, the organization has invested in early-stage research to advance therapies into human clinical trials and expand access to expert care, education, and family resources. The screening event is supported by a UC Irvine Campus-Community Collaboration Incubator award.
